Roth T - Search Results

1

A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.

Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, Canafax D, Barrett RW; XP021 Study Group. Kushida CA, et al. Among authors: roth t. Sleep. 2009 Feb;32(2):159-68. doi: 10.1093/sleep/32.2.159. Sleep. 2009. PMID: 19238802 Free PMC article. Clinical Trial.

2

Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).

Ondo WG, Grieger F, Moran K, Kohnen R, Roth T. Ondo WG, et al. Among authors: roth t. J Clin Sleep Med. 2016 Jan;12(1):63-70. doi: 10.5664/jcsm.5396. J Clin Sleep Med. 2016. PMID: 26446245 Free PMC article. Clinical Trial.

3

Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.

Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y. Kushida CA, et al. Among authors: roth t. Sleep. 2022 Jun 13;45(6):zsab200. doi: 10.1093/sleep/zsab200. Sleep. 2022. PMID: 34358324 Free PMC article. Clinical Trial.

4

Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al.

Kushida CA, Roth T, Shapiro CM, Roy A, Rosenberg R, Ajayi AO, Seiden D, Gudeman J. Kushida CA, et al. Among authors: roth t. Sleep. 2022 Jun 13;45(6):zsac042. doi: 10.1093/sleep/zsac042. Sleep. 2022. PMID: 35695179 Free PMC article. No abstract available.

5

Eight weeks of non-nightly use of zolpidem for primary insomnia.

Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC. Walsh JK, et al. Among authors: roth t. Sleep. 2000 Dec 15;23(8):1087-96. Sleep. 2000. PMID: 11145323 Clinical Trial.

6

Dual Orexin Receptor Antagonist, Almorexant, in Elderly Patients With Primary Insomnia: A Randomized, Controlled Study.

Roth T, Black J, Cluydts R, Charef P, Cavallaro M, Kramer F, Zammit G, Walsh J. Roth T, et al. Sleep. 2017 Feb 1;40(2). doi: 10.1093/sleep/zsw034. Sleep. 2017. PMID: 28364509 Clinical Trial.

7

Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.

Roth T, Roehrs T, Vogel G. Roth T, et al. Sleep. 1995 May;18(4):246-51. doi: 10.1093/sleep/18.4.246. Sleep. 1995. PMID: 7618022 Clinical Trial.

8

Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study.

Roth T, Wright KP Jr, Walsh J. Roth T, et al. Sleep. 2006 Mar;29(3):335-41. doi: 10.1093/sleep/29.3.335. Sleep. 2006. PMID: 16553019 Clinical Trial.

9

Minimal rebound insomnia after treatment with 10-mg zolpidem.

Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW. Ware JC, et al. Among authors: roth t. Clin Neuropharmacol. 1997 Apr;20(2):116-25. doi: 10.1097/00002826-199704000-00002. Clin Neuropharmacol. 1997. PMID: 9099463 Clinical Trial.

10

A new questionnaire to detect sleep disorders.

Roth T, Zammit G, Kushida C, Doghramji K, Mathias SD, Wong JM, Buysse DJ. Roth T, et al. Sleep Med. 2002 Mar;3(2):99-108. doi: 10.1016/s1389-9457(01)00131-9. Sleep Med. 2002. PMID: 14592227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,282 results

Search Page